Literature DB >> 27867969

The hunt for fatal myocardial infarction biomarkers: predictive circulating microRNAs.

Francesco Russo1, Milena Rizzo2, Kirstine Belling1, Søren Brunak1, Lasse Folkersen3.   

Abstract

Entities:  

Year:  2016        PMID: 27867969      PMCID: PMC5104639          DOI: 10.21037/atm.2016.08.21

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  18 in total

1.  Prospective study on circulating MicroRNAs and risk of myocardial infarction.

Authors:  Anna Zampetaki; Peter Willeit; Lindsey Tilling; Ignat Drozdov; Marianna Prokopi; Jean-Marie Renard; Agnes Mayr; Siegfried Weger; Georg Schett; Ajay Shah; Chantal M Boulanger; Johann Willeit; Philip J Chowienczyk; Stefan Kiechl; Manuel Mayr
Journal:  J Am Coll Cardiol       Date:  2012-07-24       Impact factor: 24.094

Review 2.  Therapeutic targeting of microRNAs: current status and future challenges.

Authors:  Zhonghan Li; Tariq M Rana
Journal:  Nat Rev Drug Discov       Date:  2014-07-11       Impact factor: 84.694

3.  Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - The HUNT study.

Authors:  Anja Bye; Helge Røsjø; Javaid Nauman; Gustavo J J Silva; Turid Follestad; Torbjørn Omland; Ulrik Wisløff
Journal:  J Mol Cell Cardiol       Date:  2016-05-15       Impact factor: 5.000

4.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

5.  Framingham risk score and prediction of lifetime risk for coronary heart disease.

Authors:  Donald M Lloyd-Jones; Peter W F Wilson; Martin G Larson; Alexa Beiser; Eric P Leip; Ralph B D'Agostino; Daniel Levy
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

6.  Increasing value and reducing waste in research design, conduct, and analysis.

Authors:  John P A Ioannidis; Sander Greenland; Mark A Hlatky; Muin J Khoury; Malcolm R Macleod; David Moher; Kenneth F Schulz; Robert Tibshirani
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

7.  U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.

Authors:  Fabian Benz; Christoph Roderburg; David Vargas Cardenas; Mihael Vucur; Jérémie Gautheron; Alexander Koch; Henning Zimmermann; Jörn Janssen; Lukas Nieuwenhuijsen; Mark Luedde; Norbert Frey; Frank Tacke; Christian Trautwein; Tom Luedde
Journal:  Exp Mol Med       Date:  2013-09-20       Impact factor: 8.718

8.  Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material.

Authors:  Victoria El-Khoury; Sandrine Pierson; Tony Kaoma; François Bernardin; Guy Berchem
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

9.  Comparing the MicroRNA spectrum between serum and plasma.

Authors:  Kai Wang; Yue Yuan; Ji-Hoon Cho; Sara McClarty; David Baxter; David J Galas
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Why current publication practices may distort science.

Authors:  Neal S Young; John P A Ioannidis; Omar Al-Ubaydli
Journal:  PLoS Med       Date:  2008-10-07       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.